Literature DB >> 7957633

Phorbol esters alter functions of the expressed dopamine transporter.

S Kitayama1, T Dohi, G R Uhl.   

Abstract

Recent elucidation of the amino acid sequences of the neurotransmitter transporters reveals several consensus sequences for phosphorylation by kinases including protein kinase C. Protein kinase C activation did modulate the function of the rat dopamine transporter expressed in COS cells. Cell treatment with the protein kinase C activator phorbol 12-myristate 13-acetate (PMA) reduced the affinity of binding of the radiolabeled cocaine analog [3H](-)-2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane (WIN 35,428) without affecting its Bmax. The uptake of [3H]dopamine was reduced by treatment with PMA in a staurosporine-sensitive manner. Kinetic analysis revealed that the inhibitory effect of PMA on [3H]dopamine uptake was due to reduced uptake velocity and a small reduction of affinity for Na+, without changed affinity for dopamine. 1-Oleoyl-2-acetyl-sn-glycerol (OAG) mimicked these actions of PMA. These results demonstrate that activation of protein kinase C alters dopamine transporter functions in both ligand recognition and substrate translocation. These phosphorylation phenomena in vitro suggest the possibility that phosphorylation could modulate the activity of this important dopaminergic synaptic regulator under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957633     DOI: 10.1016/0922-4106(94)90180-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Avenues for the development of therapeutics that target trace amine associated receptor 1 (TAAR1).

Authors:  Gregory M Miller
Journal:  J Med Chem       Date:  2012-01-20       Impact factor: 7.446

2.  Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.

Authors:  V Sandoval; E L Riddle; Y V Ugarte; G R Hanson; A E Fleckenstein
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

3.  Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding.

Authors:  Amy E Moritz; James D Foster; Balachandra K Gorentla; Michelle S Mazei-Robison; Jae-Won Yang; Harald H Sitte; Randy D Blakely; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2012-11-16       Impact factor: 5.157

Review 4.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

5.  Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor.

Authors:  Frank J S Lee; Lin Pei; Anna Moszczynska; Brian Vukusic; Paul J Fletcher; Fang Liu
Journal:  EMBO J       Date:  2007-03-22       Impact factor: 11.598

6.  Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression.

Authors:  Y Qian; A Galli; S Ramamoorthy; S Risso; L J DeFelice; R D Blakely
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

Review 7.  Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.

Authors:  Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  AAPS J       Date:  2005-10-27       Impact factor: 4.009

8.  The role of monoamine metabolism in oxidative glutamate toxicity.

Authors:  P Maher; J B Davis
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

9.  Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.

Authors:  F S Hall; K Itokawa; A Schmitt; R Moessner; I Sora; K P Lesch; G R Uhl
Journal:  Neuropharmacology       Date:  2013-08-24       Impact factor: 5.250

10.  A Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine Reuptake.

Authors:  Beryl Luk; Mohinuddin Mohammed; Fang Liu; Frank J S Lee
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.